Document Type

Journal Article

Publication Title

Journal of Infection and Public Health

Volume

16

Issue

1

First Page

125

Last Page

132

PubMed ID

36516647

Publisher

Elsevier

School

Centre for Precision Health

RAS ID

53022

Funders

Beijing Municipal Health System Special Funds of High-Level Medical Personnel Construction (grant number 2022-3-042) / China Scholarship Council (grant number 202008110060)

Comments

Wang, Y., Zhang, Y., Zhang, M., Zhang, X., Li, H., Wang, Y., ... & Zheng, D. (2023). The prevalence of adverse reactions among individuals with three-dose COVID-19 vaccination. Journal of Infection and Public Health, 16(1), 125-132. https://doi.org/10.1016/j.jiph.2022.12.004

Abstract

Background: Considering the adverse reactions to vaccination against coronavirus disease 2019 (COVID-19), some people, particularly the elderly and those with underlying medical conditions, are hesitant to be vaccinated. This study aimed to explore the prevalence of adverse reactions and provide direct evidence of vaccine safety, mainly for the elderly and people with underlying medical conditions, to receive COVID-19 vaccination. Methods: From 1st March to 30th April 2022, we conducted an online survey of people who had completed three doses of COVID-19 vaccination by convenience sampling. Adverse reaction rates and 95% confidence intervals were calculated. In addition, conditional logistic regression was used to compare the differences in adverse reactions among the elderly and those with underlying medical conditions with the general population. Results: A total of 3339 individuals were included in this study, of which 2335 (69.9%) were female, with an average age of 32.1 ± 11.4 years. The prevalence of adverse reactions after the first dose of inactivated vaccine was 24.6 % (23.1 – 26.2 %), 19.2 % (17.8 – 20.7 %) for the second dose, and 19.1 % (17.7 – 20.6 %) for the booster dose; among individuals using messenger RNA vaccines, the prevalence was 42.7 % (32.3 – 53.6 %) for the first dose, 47.2 % (36.5 – 58.1 %) for the second dose, and 46.1 % (35.4 – 57.0 %) for the booster dose. Compared with the general population, the prevalence of adverse events did not differ in individuals with underlying medical conditions and those aged 60 and above. Conclusions: For individuals with underlying medical conditions and those aged 60 and above, the prevalence of adverse reactions is similar to that of the general population, which provides a scientific basis regarding vaccination safety for these populations.

DOI

10.1016/j.jiph.2022.12.004

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Included in

Epidemiology Commons

Share

 
COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.